These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17564440)

  • 21. Origin, structure, and activity in vitro and in vivo of dalbavancin.
    Malabarba A; Goldstein BP
    J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii15-20. PubMed ID: 15750032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vancomycin resistance: are there better glycopeptides coming?
    Linden PK
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):917-28. PubMed ID: 19053904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z; Cao B; Liu YM; Gu L; Wang C
    Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of bacteriocin production and virulence traits in vancomycin-resistant enterococci of different sources.
    Sabia C; de Niederhäusern S; Guerrieri E; Messi P; Anacarso I; Manicardi G; Bondi M
    J Appl Microbiol; 2008 Apr; 104(4):970-9. PubMed ID: 18005029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hybrid Antibiotics Based on Azithromycin and Glycopeptides: Synthesis and Antibacterial Activity.
    Printsevskaya SS; Korolev AM; Isakova EB; Mirchink EP; Tevyashova AN
    Antibiot Khimioter; 2016; 61(11-12):3-8. PubMed ID: 29558054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dynamic relationship between antibiotic use and the incidence of vancomycin-resistant Enterococcus: time-series modelling of 7-year surveillance data in a tertiary-care hospital.
    Kritsotakis EI; Christidou A; Roumbelaki M; Tselentis Y; Gikas A
    Clin Microbiol Infect; 2008 Aug; 14(8):747-54. PubMed ID: 18727798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mode of action of Van-M-02, a novel glycopeptide inhibitor of peptidoglycan synthesis, in vancomycin-resistant bacteria.
    Miura K; Yamashiro H; Uotani K; Kojima S; Yutsudo T; Lu J; Yoshida O; Yamano Y; Maki H; Arimoto H
    Antimicrob Agents Chemother; 2010 Feb; 54(2):960-2. PubMed ID: 19933802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D-Ala-D-lac binding is not required for the high activity of vancomycin dimers against vancomycin resistant enterococci.
    Jain RK; Trias J; Ellman JA
    J Am Chem Soc; 2003 Jul; 125(29):8740-1. PubMed ID: 12862465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of simple macrocycles active against vancomycin-resistant enterococci (VRE).
    Jia Y; Ma N; Liu Z; Bois-Choussy M; Gonzalez-Zamora E; Malabarba A; Brunati C; Zhu J
    Chemistry; 2006 Jul; 12(20):5334-51. PubMed ID: 16634107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low prevalence of vancomycin- and bifunctional aminoglycoside-resistant enterococci isolated from poultry farms in Malaysia.
    Chan YY; Abd Nasir MH; Yahaya MA; Salleh NM; Md Dan AD; Musa AM; Ravichandran M
    Int J Food Microbiol; 2008 Feb; 122(1-2):221-6. PubMed ID: 18187222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of genetic diversity and incidence of virulence factors and antibiotic resistance among enterococcal populations from raw fruit and vegetable foods, water and soil, and clinical samples.
    Abriouel H; Omar NB; Molinos AC; López RL; Grande MJ; Martínez-Viedma P; Ortega E; Cañamero MM; Galvez A
    Int J Food Microbiol; 2008 Mar; 123(1-2):38-49. PubMed ID: 18180067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure determination and total synthesis of bottromycin A2: a potent antibiotic against MRSA and VRE.
    Shimamura H; Gouda H; Nagai K; Hirose T; Ichioka M; Furuya Y; Kobayashi Y; Hirono S; Sunazuka T; Omura S
    Angew Chem Int Ed Engl; 2009; 48(5):914-7. PubMed ID: 19115340
    [No Abstract]   [Full Text] [Related]  

  • 33. [Structure-activity relationships in a series of semisynthetic polycyclic glycopeptide antibiotics].
    Olsuf'eva EN; Preobrazhenskaia MN
    Bioorg Khim; 2006; 32(4):339-59. PubMed ID: 16909859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility to vancomycin and other antibiotics of 165 Enterococcus strains isolated from dogs in Italy.
    Ossiprandi MC; Bottarelli E; Cattabiani F; Bianchi E
    Comp Immunol Microbiol Infect Dis; 2008 Jan; 31(1):1-9. PubMed ID: 17881054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
    Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and molecular characterization of vancomycin resistant Enterococci isolates in India.
    Khudaier BY; Tewari R; Shafiani S; Sharma M; Emmanuel R; Sharma M; Taneja N
    Scand J Infect Dis; 2007; 39(8):662-70. PubMed ID: 17654341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vancomycin-resistant enterococci: prevalence and factors associated with intestinal colonization in oncology patients from Hospital de Niños de Córdoba].
    Reale AL; Depetri ML; Culasso C; Paviolo M; Cheguirián ML; Enrico MC; Ledesma EM; Vidal C; Glatstein E; Bertoni L
    Rev Argent Microbiol; 2009; 41(2):92-6. PubMed ID: 19623898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity.
    Willems RJ; Bonten MJ
    Curr Opin Infect Dis; 2007 Aug; 20(4):384-90. PubMed ID: 17609597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal heterogeneity of clinical isolates of vancomycin-resistant Enterococcus faecium with unique vanS.
    Pourshafie MR; Talebi M; Saifi M; Katouli M; Eshraghi S; Kühn I; Möllby R
    Trop Med Int Health; 2008 May; 13(5):722-7. PubMed ID: 18373511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.